Clinical Trials Directory

Trials / Unknown

UnknownNCT05125666

Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection

Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection: (A Randomized Controlled Trial)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
5 Years – 10 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the effect of using a selected dual-task- training program to improve postural stability in children with ataxia after medulloblastoma resection. Thirty patients will participate in this study. Patients will be classified randomly into two equal groups: study and control groups -Both groups will receive conventional physical therapy treatment including mobility exercises, balance exercises, gait training exercises, and exercises to improve physical conditioning. In addition, the study group will receive a selected dual-task training program including balance and cognitive activities. The treatment program will be conducted three days per week for eight successive weeks. The patients will be assessed with the Scale of Assessment and Rating of Ataxia, Humac Balance System, the Pediatric Balance Scale and Functional Independent Measurement. The measures will be recorded two times: before the application of the treatment program (pre) and after the end of the treatment program (post).

Conditions

Interventions

TypeNameDescription
OTHERDual Task Training (Motor + Cognitive)Each child in this group will perform one-hour session consist of two tasks (cognitive and balance task) in addition to the traditional physical therapy program three times weekly for 8 successive weeks.
OTHERTraditional Regular ExerciseEach child in this group will receive the selected physical therapy program which include mobility exercises, strengthening exercises, balance exercises, gait training exercises, and exercises to improve physical conditioning for one-hour session three times weekly for 8 successive weeks.

Timeline

Start date
2020-10-01
Primary completion
2022-01-01
Completion
2022-03-01
First posted
2021-11-18
Last updated
2021-11-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05125666. Inclusion in this directory is not an endorsement.